| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/20/1997 | EP0790245A1 Substituted Thiophenylalkenylcarbonylguanidide, method for their preparation, their use as medicinal or diagnostic agent as well as medicament containing them |
| 08/20/1997 | EP0790239A1 Novel 4-phenyl-2-(piperazinyl/perhydrodiazepinyl/aminoalkyl)carbonylmethyl)-1,4-dihydropyridine-3,5-dicarboxylic acid derivatives as bradykinin receptor antagonists |
| 08/20/1997 | EP0790237A1 Bicyclolactam compounds, use of the same and intermediate in the production of the same |
| 08/20/1997 | EP0790236A1 Pro-drugs of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one |
| 08/20/1997 | EP0790235A1 Diaryl alkane derivatives containing an alicyclic group, their preparation and their therapeutic and prophylactic uses |
| 08/20/1997 | EP0790234A1 Process for the preparation of aromatic nitriles |
| 08/20/1997 | EP0790058A1 Therapeutic use of transdermal naloxone (naloxone TTS) |
| 08/20/1997 | EP0790056A1 Preventive or remedy for diseases caused by abnormalities in cartilage tissues |
| 08/20/1997 | EP0790053A1 Use of 2-amino-alkane-1,3-diol to reduce hairloss and/or to induce and stimulate hairgrowth |
| 08/20/1997 | EP0789777A1 Polysaccharides having a high iduronic acid content |
| 08/20/1997 | EP0789715A1 Complementarily bonded two- and three-dimensional supramolecular structures |
| 08/20/1997 | EP0789707A1 Amino acid nucleic acids |
| 08/20/1997 | EP0789706A1 Sugar modified nucleosides and their use for synthesis of oligonucleotides |
| 08/20/1997 | EP0789702A1 Substituted tetracyclic oxazepine and thiazepine derivatives with 5-ht2 receptor affinity |
| 08/20/1997 | EP0789701A1 Substituted tetracyclic azepine derivatives which have affinity for 5-ht2 receptors |
| 08/20/1997 | EP0789700A1 Improved process for making a d-(+)-biotine intermediate product |
| 08/20/1997 | EP0789699A1 SPIRO HETEROCYCLE-IMIDAZO(1,2-a]INDENO(1,2-e]PYRAZINE]-4'-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 08/20/1997 | EP0789697A1 NOVEL CRYSTAL FORM OF ANHYDROUS 7-((1a,5a, 6a)-6-AMINO-3-AZABICYCLO ( 3.1.0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT |
| 08/20/1997 | EP0789695A2 Thiepane compounds inhibiting and detecting hiv protease |
| 08/20/1997 | EP0789690A1 N-aryl and n-heteroaryl-1,2-diaminocyclobutene-3,4-diones with smooth muscle relaxing activities |
| 08/20/1997 | EP0789687A1 Ep 2?-receptor agonists as agents for lowering intraocular pressure |
| 08/20/1997 | EP0789686A1 Retinoylamide based derivatives of sphingoid bases |
| 08/20/1997 | EP0789593A1 Yeast-based delivery vehicles |
| 08/20/1997 | EP0789590A2 Chitosan induced immunopotentiation |
| 08/20/1997 | EP0789578A1 Multicatalytic protease inhibitors |
| 08/20/1997 | EP0789575A1 Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 08/20/1997 | EP0789574A1 Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| 08/20/1997 | EP0789572A1 Cisapride extended release oral compositions |
| 08/20/1997 | EP0789571A1 Cyclic amidine analogs as inhibitors of nitric oxide synthase |
| 08/20/1997 | EP0789570A1 Oral hypoglycemic agents |
| 08/20/1997 | EP0789569A2 Use of benzothiophenes and benzofurans for the treatment of inflammatory bowel disease and inflammation assay method |
| 08/20/1997 | EP0789568A1 Antineoplastic cocoa extracts, methods for making, using |
| 08/20/1997 | EP0789567A1 A method for treating vascular headaches |
| 08/20/1997 | EP0789566A1 Hydroxyethyl aminimides |
| 08/20/1997 | EP0789565A1 Prevention of hiv infection |
| 08/20/1997 | EP0789564A1 Polynucleotide compositions |
| 08/20/1997 | EP0789563A1 Hepatitis virus vaccines |
| 08/20/1997 | EP0789562A1 Sustained release caffeine formulation |
| 08/20/1997 | EP0789560A1 A novel pharmaceutical for oral administration comprising progresterone and a polyethyelene glycol together with an excipient |
| 08/20/1997 | EP0789559A1 Pharmaceutical composition containing a fusible carrier and method for producing the same |
| 08/20/1997 | EP0789555A1 Dimeric acids in cosmetic or pharmaceutical compositions |
| 08/20/1997 | EP0789553A1 Antiodor, antimicrobial and preservative compositions and methods of using same |
| 08/20/1997 | EP0752813A4 Inhibitors of metazoan parasite proteases |
| 08/20/1997 | EP0705102B1 Use of corrinoids in topical treatment of skin diseases |
| 08/20/1997 | EP0701571B1 Antibody fragments in therapy |
| 08/20/1997 | EP0679155B1 Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 08/20/1997 | EP0662954B1 Novel vitamin d analogues |
| 08/20/1997 | EP0654035B1 Phosphonoacetic esters and acids as anti-inflammatories |
| 08/20/1997 | EP0629197B1 1-alkoxy-(2-alkoxy- or cycloalkoxy)-4-(cyclo thioalkyl- or cyclothioalkenyl)benzenes as inhibitors of cyclic amp phosphodiesterase and tumour necrosis factor |
| 08/20/1997 | EP0579833B1 Ethanolamine derivatives with anti-pollakiuria activity |
| 08/20/1997 | EP0531495B1 Therapeutic and cosmetic compositions for treatment of skin |
| 08/20/1997 | EP0502031B1 N-substituted azaheterocyclic carboxylic acids and a pharmaceutical composition |
| 08/20/1997 | EP0464150B1 Skin permeation enhancer compositions |
| 08/20/1997 | CN1157619A Pyrimido £5-4-d| pyrimidines, drugs containing these compounds, their use and process for preparing them |
| 08/20/1997 | CN1157618A Novel substituted purinyl derivatives with immunomodulating activity |
| 08/20/1997 | CN1157617A Heterobicyclic derivatives |
| 08/20/1997 | CN1157615A Heterocyclic tachykinin receptor antagonists |
| 08/20/1997 | CN1157614A Process for synthesis of substituted sulphoxides |
| 08/20/1997 | CN1157613A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/20/1997 | CN1157611A Novel quinolone 5-(N-heterosubstituted amino) antimicrobials |
| 08/20/1997 | CN1157610A Thiopyridyl compounds for controlling helicobacter bacteria |
| 08/20/1997 | CN1157609A Heterocyclic derivative and medicine |
| 08/20/1997 | CN1157608A Stable vitamin A |
| 08/20/1997 | CN1157571A Use of IL-4 for potentiation of chemotherapeutic agents |
| 08/20/1997 | CN1157570A Intracellular delivery of chemical agents to specific cell type |
| 08/20/1997 | CN1157569A Anti-adhesion agent |
| 08/20/1997 | CN1157568A Hard tissue stimulating agent |
| 08/20/1997 | CN1157567A Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin |
| 08/20/1997 | CN1157566A Phosphonates and parathyroid hormone for osteoporosis |
| 08/20/1997 | CN1157565A Method for treatment of osteoporosis using bone active phosphonates and parathyroid hormone |
| 08/20/1997 | CN1157564A Method of treating opportunistic infections with azaspiranes |
| 08/20/1997 | CN1157551A Sprayable film forming system releasing active substances for use on plants |
| 08/20/1997 | CN1157288A Benzimidazole derivatives, their preparation and their therapeutic use |
| 08/20/1997 | CN1157287A Arylalkyl diazinones |
| 08/20/1997 | CN1157286A N,N-dimethyl-1-t-butoxycarbonyl-4-phenylpiperidine-4-carboxamide |
| 08/20/1997 | CN1157258A CO2 absorption indicator and reagent kit for diagnosing pyloric Helicobacterium |
| 08/20/1997 | CN1157137A Cream for curing eczema |
| 08/20/1997 | CN1157136A Pharmaceutical agents for treatment of acute and chronic inflammatory diseases |
| 08/20/1997 | CN1035675C Novel process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives |
| 08/20/1997 | CN1035673C Preparation method for megnesium gluconate for medicine use |
| 08/20/1997 | CN1035670C Method for preparing benzoheterocyclic compounds or its salt |
| 08/20/1997 | CN1035655C Method for improved fish production and its feed |
| 08/19/1997 | USRE35593 Therapy for dermentia |
| 08/19/1997 | US5659083 Process of preparing 2,2'-(1-methyl-1,2-ethanediylidene) bis[hydrazinecarboximidamide] |
| 08/19/1997 | US5659082 Nitro- and aminobenzamide compounds for neurodegenerative disorders |
| 08/19/1997 | US5659063 Intermediates for amidino phenyl pyrrolidine β-alanine urea analogs |
| 08/19/1997 | US5659061 Antitumor agents, enzyme inhibitors |
| 08/19/1997 | US5659048 Chiral [[(2-bromoethyl)-amino]methyl]-2-nitro-1H-imidazol-1-ethanol and related compounds |
| 08/19/1997 | US5659047 Polyfluoroalkylthiopoly (ethylimidazolium) compounds, preparation process and their use as biocidal agents |
| 08/19/1997 | US5659045 Retroviral protease inhibiting compounds |
| 08/19/1997 | US5659044 Retroviral protease inhibiting compounds |
| 08/19/1997 | US5659038 Grampositive/gramnegative microbiocides; antiseptics, human and veterinary medicine |
| 08/19/1997 | US5659033 Psychological disorders |
| 08/19/1997 | US5659030 Antibiotic drug in crystal form |
| 08/19/1997 | US5659027 Boronated compounds |
| 08/19/1997 | US5659025 In vivo/in vitro detection of genetic material |
| 08/19/1997 | US5659018 Mocarhagin, a cobra venom protease, and therapeutic uses thereof |
| 08/19/1997 | US5658958 β, γ-dihydropolyprenyl alcohol derivatives effective at mitigating stress in animals |
| 08/19/1997 | US5658957 Immunostimulating wound healing compositions and method for preparing and using same |
| 08/19/1997 | US5658956 Bioadhesive-wound healing compositions and methods for preparing and using same |